Synthetic antimalaria drug enters clinical trials.
Jane
J
Bradbury
D000962:Antimalarials / Q000191:economics / Q000627:therapeutic use*; D037621:Artemisinins / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016527:Drug Costs; D015195:Drug Design; D004359:Drug Therapy, Combination; D006573:Heterocyclic Compounds, 1-Ring / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D010545:Peroxides; D012109:Research Support as Topic; D012717:Sesquiterpenes / Q000627:therapeutic use; D013141:Spiro Compounds / Q000191:economics / Q000627:therapeutic use*; D013785:Thailand
D000962:Antimalarials; D037621:Artemisinins; D006573:Heterocyclic Compounds, 1-Ring; D010545:Peroxides; D012717:Sesquiterpenes; D013141:Spiro Compounds; C489136:arterolane; C031327:artemisinin